Is cardiomyopathy an autoimmune disease?

Area of Science:

• Cardiology
• Immunology
• Genetics

Background:

• Idiopathic dilated cardiomyopathy (DCM) is a primary cause of heart failure and heart transplantation.
• DCM presents with ventricular dilation and contractile dysfunction, with both familial and sporadic forms.
• Despite therapeutic advances, DCM incidence and mortality remain high due to its heterogeneous etiology.

Purpose of the Study:

• To investigate the role of autoimmune mechanisms in the pathogenesis of idiopathic dilated cardiomyopathy.
• To explore the presence and significance of autoantibodies in DCM patient sera.
• To differentiate between autoimmune-mediated DCM and other forms of the disease.

Main Methods:

• Review of existing literature on DCM etiology, focusing on immune factors.
• Analysis of studies identifying autoantibodies (e.g., anti-receptor, anti-myosin) in DCM patients.
• Evaluation of in-vitro and in-vivo data supporting autoimmunity in DCM subgroups.

Main Results:

• Evidence suggests multiple autoimmune mechanisms contribute to subsets of DCM.
• Various circulating autoantibodies, including antireceptor and anti-myosin antibodies, are found in DCM patients.
• Studies indicate that a distinct subgroup of DCM is mediated by autoimmunity.

Conclusions:

• DCM is a heterogeneous condition with diverse underlying causes.
• Autoimmune mechanisms are implicated in a significant subgroup of DCM patients.
• Future clinical practice may involve distinguishing "autoimmune cardiomyopathy" from other idiopathic DCM cases.